Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01486407
Other study ID # 2011-13
Secondary ID
Status Terminated
Phase N/A
First received December 2, 2011
Last updated January 31, 2013
Start date February 2012
Est. completion date December 2012

Study information

Verified date January 2013
Source Vidacare Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.


Description:

This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access from the perspective of the medical professional performing rapid sequence intubation. The investigators believe that medical professionals will find equal intubating conditions for intravenous and intraosseous drug delivery.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Requires rapid sequence intubation

- Succinylcholine is chosen paralytic agent

- IV or IO access has been established for rapid sequence intubation

- For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO RSI case.

Exclusion Criteria:

- Vascular access other than IV or IO has been established

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Christus Spohn Hospital Corpus Christi Corpus Christi Texas
United States Texas Tech University Health Science Center El Paso El Paso Texas

Sponsors (1)

Lead Sponsor Collaborator
Vidacare Corporation

Country where clinical trial is conducted

United States, 

References & Publications (10)

Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7. — View Citation

Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. doi: 10.1097/CCM.0b013e31819323c6. Erratum in: Crit Care Med. 2009 Apr;37(4):1536. Skache, Sara [corrected to Kache, Saraswati]; Irazusta, Jose [corrected to Irazuzta, Jose]. — View Citation

Deakin CD, Nolan JP, Sunde K, Koster RW. European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing. Resuscitation. 2010 Oct;81(10):1293-304. doi: 10.1016/j.resuscitation.2010.08.008. — View Citation

Kleinman ME, de Caen AR, Chameides L, Atkins DL, Berg RA, Berg MD, Bhanji F, Biarent D, Bingham R, Coovadia AH, Hazinski MF, Hickey RW, Nadkarni VM, Reis AG, Rodriguez-Nunez A, Tibballs J, Zaritsky AL, Zideman D; Pediatric Basic and Advanced Life Support Chapter Collaborators. Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics. 2010 Nov;126(5):e1261-318. doi: 10.1542/peds.2010-2972A. Epub 2010 Oct 18. — View Citation

Laurin EG, Sakles JC, Panacek EA, Rantapaa AA, Redd J. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000 Dec;7(12):1362-9. — View Citation

Leidel BA, Kirchhoff C, Bogner V, Braunstein V, Biberthaler P, Kanz KG. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012 Jan;83(1):40-5. doi: 10.1016/j.resuscitation.2011.08.017. Epub 2011 Sep 3. — View Citation

Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, VanLente F. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child. 1990 Jan;144(1):112-7. — View Citation

Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002788. doi: 10.1002/14651858.CD002788.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD002788. — View Citation

Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011 Dec;58(6):509-16. doi: 10.1016/j.annemergmed.2011.07.020. — View Citation

Von Hoff DD, Kuhn JG, Burris HA 3rd, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med. 2008 Jan;26(1):31-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Time from first drug delivery to operator-perceived sufficient relaxation to perform endotracheal tube placement during rapid sequence intubation procedure, average expected time frame 30 minutes No
Primary Intubation difficulty using the intubation difficulty scale during rapid sequence intubation procedure, average expected time frame 30 minutes No
Primary Operator satisfaction with intubating conditions using visual analog scale during rapid sequence intubation procedure, average expected time frame 30 minutes No
Primary Failure rate of endotracheal intubation and requirement for alternative airway management methods during rapid sequence intubation procedure, average time frame 30 minutes No
Secondary Incidence of short-term catheter related complications for each technique during emergency department stay, average time frame 24 hours No
See also
  Status Clinical Trial Phase
Completed NCT01823328 - Ketamine Versus Etomidate for Rapid Sequence Intubation Phase 4
Withdrawn NCT01634867 - Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients N/A
Completed NCT01765530 - Efficacy Study of a Novel Device to Clean the Endotracheal Tube N/A
Withdrawn NCT04258215 - PSA (Pharachute Supralaryngeal Airway) for Positive Pressure Ventilation (PPV) N/A
Recruiting NCT04924621 - Sedation Compaired With Anesthesia With THRIVE in Endotracheal Intubation With Difficult Airways N/A
Recruiting NCT04080440 - Brain-injured Patients Extubation Readiness Study N/A
Recruiting NCT04100564 - LITES Task Order 0005 Prehospital Airway Control Trial (PACT) N/A